SEC Form 4 · accession 0001209191-18-001965
Minerva Neurosciences, Inc. · NERV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Remy Luthringer
Officer — CEO · Director
Period of report
Jan 2, 2018
Accepted (ET)
Jan 4, 2018 · 4:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001598646
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $6.20 | Jan 2, 2018 | A | 200,000 | A | — | Jan 2, 2028 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1This option vests as to 25% of the shares on December 13, 2018 and then in quarterly installments over 3 years thereafter.